IBDEI2YA ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,47087,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47087,1,3,0)
;;=3^Secondary Malig Neop Bone Marrow
;;^UTILITY(U,$J,358.3,47087,1,4,0)
;;=4^C79.52
;;^UTILITY(U,$J,358.3,47087,2)
;;=^5001351
;;^UTILITY(U,$J,358.3,47088,0)
;;=Z12.9^^181^2351^15
;;^UTILITY(U,$J,358.3,47088,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47088,1,3,0)
;;=3^Screening Malig Neop Site Unspec
;;^UTILITY(U,$J,358.3,47088,1,4,0)
;;=4^Z12.9
;;^UTILITY(U,$J,358.3,47088,2)
;;=^5062698
;;^UTILITY(U,$J,358.3,47089,0)
;;=D17.9^^181^2351^2
;;^UTILITY(U,$J,358.3,47089,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47089,1,3,0)
;;=3^Benign Neop Lipomatous,Unspec
;;^UTILITY(U,$J,358.3,47089,1,4,0)
;;=4^D17.9
;;^UTILITY(U,$J,358.3,47089,2)
;;=^5002020
;;^UTILITY(U,$J,358.3,47090,0)
;;=E11.9^^181^2352^15
;;^UTILITY(U,$J,358.3,47090,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47090,1,3,0)
;;=3^Diabetes Type 2 w/o Complications
;;^UTILITY(U,$J,358.3,47090,1,4,0)
;;=4^E11.9
;;^UTILITY(U,$J,358.3,47090,2)
;;=^5002666
;;^UTILITY(U,$J,358.3,47091,0)
;;=E10.9^^181^2352^12
;;^UTILITY(U,$J,358.3,47091,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47091,1,3,0)
;;=3^Diabetes Type 1 w/o Complications
;;^UTILITY(U,$J,358.3,47091,1,4,0)
;;=4^E10.9
;;^UTILITY(U,$J,358.3,47091,2)
;;=^5002626
;;^UTILITY(U,$J,358.3,47092,0)
;;=E11.65^^181^2352^14
;;^UTILITY(U,$J,358.3,47092,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47092,1,3,0)
;;=3^Diabetes Type 2 w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,47092,1,4,0)
;;=4^E11.65
;;^UTILITY(U,$J,358.3,47092,2)
;;=^5002663
;;^UTILITY(U,$J,358.3,47093,0)
;;=E10.65^^181^2352^11
;;^UTILITY(U,$J,358.3,47093,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47093,1,3,0)
;;=3^Diabetes Type 1 w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,47093,1,4,0)
;;=4^E10.65
;;^UTILITY(U,$J,358.3,47093,2)
;;=^5002623
;;^UTILITY(U,$J,358.3,47094,0)
;;=E86.0^^181^2352^1
;;^UTILITY(U,$J,358.3,47094,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47094,1,3,0)
;;=3^Dehydration
;;^UTILITY(U,$J,358.3,47094,1,4,0)
;;=4^E86.0
;;^UTILITY(U,$J,358.3,47094,2)
;;=^332743
;;^UTILITY(U,$J,358.3,47095,0)
;;=F03.90^^181^2352^4
;;^UTILITY(U,$J,358.3,47095,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47095,1,3,0)
;;=3^Dementia w/o Behavioral Disturbance
;;^UTILITY(U,$J,358.3,47095,1,4,0)
;;=4^F03.90
;;^UTILITY(U,$J,358.3,47095,2)
;;=^5003050
;;^UTILITY(U,$J,358.3,47096,0)
;;=F02.80^^181^2352^3
;;^UTILITY(U,$J,358.3,47096,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47096,1,3,0)
;;=3^Dementia in Oth Diseases w/o Behavioral Disturbance
;;^UTILITY(U,$J,358.3,47096,1,4,0)
;;=4^F02.80
;;^UTILITY(U,$J,358.3,47096,2)
;;=^5003048
;;^UTILITY(U,$J,358.3,47097,0)
;;=F02.81^^181^2352^2
;;^UTILITY(U,$J,358.3,47097,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47097,1,3,0)
;;=3^Dementia in Oth Diseases w/ Behavioral Disturbance
;;^UTILITY(U,$J,358.3,47097,1,4,0)
;;=4^F02.81
;;^UTILITY(U,$J,358.3,47097,2)
;;=^5003049
;;^UTILITY(U,$J,358.3,47098,0)
;;=F32.9^^181^2352^6
;;^UTILITY(U,$J,358.3,47098,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,47098,1,3,0)
;;=3^Depressive Disorder,Major,Single Episode,Unspec
;;^UTILITY(U,$J,358.3,47098,1,4,0)
;;=4^F32.9
;;^UTILITY(U,$J,358.3,47098,2)
;;=^5003528
;;^UTILITY(U,$J,358.3,47099,0)
;;=K57.30^^181^2352^19
;;^UTILITY(U,$J,358.3,47099,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2YA 3768 printed Oct 16, 2024@18:38:57 Page 2
IBDEI2YA ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,47087,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,47087,1,3,0)
+4 ;;=3^Secondary Malig Neop Bone Marrow
+5 ;;^UTILITY(U,$J,358.3,47087,1,4,0)
+6 ;;=4^C79.52
+7 ;;^UTILITY(U,$J,358.3,47087,2)
+8 ;;=^5001351
+9 ;;^UTILITY(U,$J,358.3,47088,0)
+10 ;;=Z12.9^^181^2351^15
+11 ;;^UTILITY(U,$J,358.3,47088,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,47088,1,3,0)
+14 ;;=3^Screening Malig Neop Site Unspec
+15 ;;^UTILITY(U,$J,358.3,47088,1,4,0)
+16 ;;=4^Z12.9
+17 ;;^UTILITY(U,$J,358.3,47088,2)
+18 ;;=^5062698
+19 ;;^UTILITY(U,$J,358.3,47089,0)
+20 ;;=D17.9^^181^2351^2
+21 ;;^UTILITY(U,$J,358.3,47089,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,47089,1,3,0)
+24 ;;=3^Benign Neop Lipomatous,Unspec
+25 ;;^UTILITY(U,$J,358.3,47089,1,4,0)
+26 ;;=4^D17.9
+27 ;;^UTILITY(U,$J,358.3,47089,2)
+28 ;;=^5002020
+29 ;;^UTILITY(U,$J,358.3,47090,0)
+30 ;;=E11.9^^181^2352^15
+31 ;;^UTILITY(U,$J,358.3,47090,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,47090,1,3,0)
+34 ;;=3^Diabetes Type 2 w/o Complications
+35 ;;^UTILITY(U,$J,358.3,47090,1,4,0)
+36 ;;=4^E11.9
+37 ;;^UTILITY(U,$J,358.3,47090,2)
+38 ;;=^5002666
+39 ;;^UTILITY(U,$J,358.3,47091,0)
+40 ;;=E10.9^^181^2352^12
+41 ;;^UTILITY(U,$J,358.3,47091,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,47091,1,3,0)
+44 ;;=3^Diabetes Type 1 w/o Complications
+45 ;;^UTILITY(U,$J,358.3,47091,1,4,0)
+46 ;;=4^E10.9
+47 ;;^UTILITY(U,$J,358.3,47091,2)
+48 ;;=^5002626
+49 ;;^UTILITY(U,$J,358.3,47092,0)
+50 ;;=E11.65^^181^2352^14
+51 ;;^UTILITY(U,$J,358.3,47092,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,47092,1,3,0)
+54 ;;=3^Diabetes Type 2 w/ Hyperglycemia
+55 ;;^UTILITY(U,$J,358.3,47092,1,4,0)
+56 ;;=4^E11.65
+57 ;;^UTILITY(U,$J,358.3,47092,2)
+58 ;;=^5002663
+59 ;;^UTILITY(U,$J,358.3,47093,0)
+60 ;;=E10.65^^181^2352^11
+61 ;;^UTILITY(U,$J,358.3,47093,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,47093,1,3,0)
+64 ;;=3^Diabetes Type 1 w/ Hyperglycemia
+65 ;;^UTILITY(U,$J,358.3,47093,1,4,0)
+66 ;;=4^E10.65
+67 ;;^UTILITY(U,$J,358.3,47093,2)
+68 ;;=^5002623
+69 ;;^UTILITY(U,$J,358.3,47094,0)
+70 ;;=E86.0^^181^2352^1
+71 ;;^UTILITY(U,$J,358.3,47094,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,47094,1,3,0)
+74 ;;=3^Dehydration
+75 ;;^UTILITY(U,$J,358.3,47094,1,4,0)
+76 ;;=4^E86.0
+77 ;;^UTILITY(U,$J,358.3,47094,2)
+78 ;;=^332743
+79 ;;^UTILITY(U,$J,358.3,47095,0)
+80 ;;=F03.90^^181^2352^4
+81 ;;^UTILITY(U,$J,358.3,47095,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,47095,1,3,0)
+84 ;;=3^Dementia w/o Behavioral Disturbance
+85 ;;^UTILITY(U,$J,358.3,47095,1,4,0)
+86 ;;=4^F03.90
+87 ;;^UTILITY(U,$J,358.3,47095,2)
+88 ;;=^5003050
+89 ;;^UTILITY(U,$J,358.3,47096,0)
+90 ;;=F02.80^^181^2352^3
+91 ;;^UTILITY(U,$J,358.3,47096,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,47096,1,3,0)
+94 ;;=3^Dementia in Oth Diseases w/o Behavioral Disturbance
+95 ;;^UTILITY(U,$J,358.3,47096,1,4,0)
+96 ;;=4^F02.80
+97 ;;^UTILITY(U,$J,358.3,47096,2)
+98 ;;=^5003048
+99 ;;^UTILITY(U,$J,358.3,47097,0)
+100 ;;=F02.81^^181^2352^2
+101 ;;^UTILITY(U,$J,358.3,47097,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,47097,1,3,0)
+104 ;;=3^Dementia in Oth Diseases w/ Behavioral Disturbance
+105 ;;^UTILITY(U,$J,358.3,47097,1,4,0)
+106 ;;=4^F02.81
+107 ;;^UTILITY(U,$J,358.3,47097,2)
+108 ;;=^5003049
+109 ;;^UTILITY(U,$J,358.3,47098,0)
+110 ;;=F32.9^^181^2352^6
+111 ;;^UTILITY(U,$J,358.3,47098,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,47098,1,3,0)
+114 ;;=3^Depressive Disorder,Major,Single Episode,Unspec
+115 ;;^UTILITY(U,$J,358.3,47098,1,4,0)
+116 ;;=4^F32.9
+117 ;;^UTILITY(U,$J,358.3,47098,2)
+118 ;;=^5003528
+119 ;;^UTILITY(U,$J,358.3,47099,0)
+120 ;;=K57.30^^181^2352^19
+121 ;;^UTILITY(U,$J,358.3,47099,1,0)
+122 ;;=^358.31IA^4^2
